NCT00790738View on ClinicalTrials.gov

Liothyronine (T3) for Bipolar Depression

PHASE3CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

DepressionBipolar Disorder

Interventions

DRUG

Liothyronine (T3)

liothyronine (T3) up to 50 micrograms a day

DRUG

placebo

placebo

Trial Locations (1)

11004

The Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Northwell Health

OTHER

NCT00790738 - Liothyronine (T3) for Bipolar Depression | Biotech Hunter | Biotech Hunter